HLTRF — Stock Film
STOCK FILMSCENE 1/11HLTRF · $2.78
Stock Expert AI presents
HLTRF
HLS Therapeutics Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
HLS Therapeutics Inc. A quick introduction.

On the stock market since 2010, it operates in the world of health and science. It has 85 employees. Now — the numbers.

on the stock market since 2010
85 employees
$96.3M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.2.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are moving sideways.

No real growth (-2% a year). Red columns mark years that ended in a loss.

$60M
2021
$61.5M
2022
$63.1M
2023
$56.6M
2024
$56.5M
2025
In the vault right now:
$0
DEBT: $49.7M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
2 / 8
EXPECTATIONS MET OR BEATEN
2
Nov 2024
Mar 2025
May 2025
Aug 2025
Nov 2025
Mar 2026
May 2026
Aug 2026
2 TIMES IN THE LAST 8 QUARTERS
It misses the bar more often than not.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
WEAK SPOTS
Growth has stalled2/10
Heavy bets against the stock2/10
The stock has lost its spark3/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 83% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Pays a steady dividend

It pays out $0.15 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Running at a loss

A loss of $12.6M against $56.5M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, HLTRF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: HLTRF is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film